Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034970
Filing Date
2024-11-13
Accepted
2024-11-13 17:20:28
Documents
98
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q aytu20240930_10q.htm   iXBRL 10-Q 1234749
2 EXHIBIT 31.1 ex_722660.htm EX-31.1 13490
3 EXHIBIT 31.2 ex_722661.htm EX-31.2 13803
4 EXHIBIT 32.1 ex_722662.htm EX-32.1 8691
10 aytu20231231_10qimg001.jpg GRAPHIC 2569
  Complete submission text file 0001437749-24-034970.txt   8146661

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA aytu-20240930.xsd EX-101.SCH 80161
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aytu-20240930_cal.xml EX-101.CAL 68351
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20240930_def.xml EX-101.DEF 542873
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20240930_lab.xml EX-101.LAB 451285
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20240930_pre.xml EX-101.PRE 594486
101 EXTRACTED XBRL INSTANCE DOCUMENT aytu20240930_10q_htm.xml XML 1338895
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38247 | Film No.: 241455734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)